A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan
CompletedOBSERVATIONAL
Enrollment
94
Participants
Timeline
Start Date
October 30, 2022
Primary Completion Date
March 1, 2023
Study Completion Date
March 1, 2023
Conditions
Carcinoma, Hepatocellular
Trial Locations (1)
Unknown
Darul Sehat Hospital, Karachi
All Listed Sponsors
lead
Darul Sehat Hospital
OTHER
NCT06629857 - A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan | Biotech Hunter | Biotech Hunter